Full-Time

Junior Clinical Research Associate

Posted on 8/18/2026

Deadline 8/28/26
Translational Research in Oncology

Translational Research in Oncology

201-500 employees

Translational cancer research in clinical trials

Compensation Overview

€45k - €52.5k/yr

+ Home office allowance + Luggage allowance + Mobile phone allowance

Paris, France

Remote

Home-based in France, with travel up to 60% on average.

Bachelor's

Category
Biology & Biotech (1)
Required Skills
FDA Regulations
Medical Terminology

Get referred to Translational Research in Oncology

See people who can refer or advise you

Requirements
  • Less than 2 years of experience as a Clinical Research Associate, or strong experience as a Research Nurse or Study Coordinator in oncology.
  • Knowledge of oncology and local regulatory requirements.
  • Fluency in French and English.
  • Completion of a science-related Bachelor's degree.
  • Knowledge of medical terminology and the clinical monitoring process.
  • Strong knowledge of International Council for Harmonisation Good Clinical Practice standards.
  • Experience with clinical trial information systems.
  • Ability to travel up to 60% on average.
Responsibilities
  • Conduct site visits, including pre-study, initiation, monitoring, and termination visits.
  • Confirm adherence to all Food and Drug Administration, International Council for Harmonisation Good Clinical Practice, and local regulations.
  • Ensure the completion and collection of regulatory documents.
  • Perform source document verification, validate Case Report Forms, and resolve queries in a timely manner to ensure clean data availability for study analyses.
  • Ensure Serious Adverse Event reporting according to project specifications.
  • Respond to requests from clinical study sites in a timely manner.
  • Assist with data validation and query resolution.
  • Assist during on-site audits when required and prepare site audit report replies.
  • Assist with implementing corrective and preventive actions when appropriate.
Desired Qualifications
  • Knowledge of oncology and local regulatory requirements would be a major asset.
Translational Research in Oncology

Translational Research in Oncology

View

TRIO is an academic clinical research organization focused on translating cancer science into patient treatments. It coordinates translational cancer research by bringing innovative, targeted therapeutic ideas into clinical trials. The group operates through an international network, with offices in Canada, France, and Uruguay and partnerships with about 2,000 investigators and 450 cancer centers in more than 45 countries, allowing global studies of systemic cancer therapies. Compared with typical biotech or pharma firms, TRIO emphasizes academic collaboration and real-world trial execution across many centers rather than developing and selling drugs itself. Its goal is to move promising cancer treatments from the lab to the clinic, testing them in trials to improve outcomes for patients.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Edmonton, Canada

Founded

1997

Get referred to Translational Research in Oncology

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • TRIO's September 2025 NATALEE follow-up strengthened ribociclib's recurrence-reduction story.
  • Great Place to Work named TRIO Uruguay among 2025's best workplaces, aiding retention.
  • Mark Pegram joined TRIO's Breast Cancer Scientific Committee in March 2025, deepening scientific credibility.

What critics are saying

  • Novartis can reallocate future trials to larger CROs after NATALEE's 2024 success.
  • TRIO's network is non-exclusive, so investigators can leave for competitor-sponsored programs anytime.
  • A failed late-stage sponsor program would immediately cut TRIO revenue and damage credibility.

What makes Translational Research in Oncology unique

  • TRIO turned NATALEE into Novartis's 2024 ribociclib approval, proving global execution.
  • TRIO-US links UCLA, community sites, and international CRO capacity without exclusivity fees.
  • TRIO's 2,000 investigators across 45 countries accelerate early-phase and registrational oncology studies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

Paid Vacation

Flexible Work Hours

Remote Work Options

Home Office Stipend

Luggage allowance

Phone/Internet Stipend

Company News

NewsNet
Oct 5th, 2023
Trio Wins Nobel Prize in Chemistry for Quantum Dots Research, Used in Electronics and Medical Imaging

Trio wins Nobel Prize in chemistry for quantum dots research, used in electronics and medical imaging.